drugset
drugset / Trial / NCT01211860

Pharmacokinetic Study of Diazoxide Choline in Hypertriglyeridemic Subjects

NCT01211860 ↗

Phase 1 Completed 9 enrolled Essentialis, Inc. Cetero Research, San Antonio · collab
Non-randomizedSingle-groupOpen-label

Summary

Once a day oral administration with DCCR is the optimal dosing regimen

Timeline

Start
2010-10
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Diazoxide Choline Unknown 290 mg Oral

Indications

hypertriglyceridemia